Understanding Kidney Filter Proteins
Structure and Function of Integrins in the Kidney
This research looks at how certain proteins in your kidney's filter work, especially in conditions like brittle diabetes, to keep your kidneys healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11071993 on NIH RePORTER |
What this research studies
Our kidneys have a special filter, called the glomerular filtration barrier, that keeps important things in your blood while removing waste. This filter relies on tiny cells called podocytes, which have proteins called integrins (α3β1 and αvβ3) and another protein called CD151. We believe that α3β1, with CD151, helps keep this filter strong, but when αvβ3 becomes active, especially during illness, it might pull CD151 away from α3β1, making the filter leaky. This project aims to understand exactly how these proteins interact and how their balance affects kidney health, particularly in diseases that damage the kidneys.
Who could benefit from this research
Good fit: Patients with kidney conditions, particularly those experiencing issues with their kidney's filtration barrier or conditions like brittle diabetes, could potentially benefit from future treatments developed from this research.
Not a fit: Patients without kidney disease or related conditions would likely not directly benefit from this specific line of research.
Why it matters
Potential benefit: This work could lead to new ways to protect the kidney's filtering system and prevent kidney damage in patients with conditions like brittle diabetes.
How similar studies have performed: Previous studies have shown that these proteins play important roles in kidney health, and preliminary findings from this team support the proposed interactions, suggesting a solid foundation for this novel investigation.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Arnaout, M. Amin — Massachusetts General Hospital
- Study coordinator: Arnaout, M. Amin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.